The study aimed to evaluate carotid atherosclerosis in patients with NAFLD by measuring CIMT and to determine its correlation with serum transaminase levels, specifically alanine aminotransferase (ALT) and aspartate aminotransferase (AST). This evidence concerns the gene GOT1 and carotid atherosclerosis.